Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dewen Zhong

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|April 23, 2019
A kidney changes size: first increasing and then decreasingDewen Zhong, Yi Yi, Chaolu Lin
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 18, 2015
Bladder leiomyosarcoma in a patient with chronic ketamine abuse: A case reportDewen Zhong, Feng Yu, Jiande Chen, et al.
American Journal of Translational Research|October 14, 2024
Analysis of relevant influencing factors for recurrent urinary tract infections in children: exploring predictive factors and intervention measuresGuilin Wang, Jian Lin, Jiongxuan Xu, et al.
Critical Reviews in Oncology/Hematology|June 16, 2026
Challenges and Recent Advances in CAR-T Cell Therapy for Solid TumorsZhixun Guo, Dewen Zhong, Dongxue Jiao, et al.
Ecotoxicology and Environmental Safety|March 20, 2026
Mechanism of benzophenone-3 in promoting proliferation and migration of prostate cancer cells via the acyl-CoA dehydrogenase 9 axisJinhui Jian, Jiongxuan Xu, Guilin Wang, et al.
Journal of Cancer|April 30, 2019
Current Treatment for Low-Risk Prostate Cancer in China: A National Network SurveyYongbao Wei, Longfei Liu, Xin Li, et al.
Scientific Reports|August 27, 2024
Low-dose abiraterone plus Olaparib as a late-line treatment for mCRPC patients without BRCA1/2 mutations: a multicenter retrospective pilot studySijin Chen, Dewen Zhong, Chenbo Yu, et al.
Frontiers in Pharmacology|November 6, 2023
Androgen deprivation therapy plus apalutamide as neoadjuvant therapy prior radical prostatectomy for patients with unresectable prostate cancerYongbao Wei, Ruochen Zhang, Dewen Zhong, et al.
World Journal of Urology|March 27, 2024
Association between the American Heart Association's new "Life's Essential 8" metrics and kidney stoneXingmo Dong, Lihua Liao, Yani Wang, et al.
Frontiers in Pharmacology|December 19, 2025
Darolutamide-based triple therapy combined with PSMA imaging guided focal treatment in patients with prostate cancer: a multicenter retrospective studyDewen Zhong, Ruochen Zhang, Jinling Wu, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|April 23, 2019
A kidney changes size: first increasing and then decreasingDewen Zhong, Yi Yi, Chaolu Lin
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 18, 2015
Bladder leiomyosarcoma in a patient with chronic ketamine abuse: A case reportDewen Zhong, Feng Yu, Jiande Chen, et al.
American Journal of Translational Research|October 14, 2024
Analysis of relevant influencing factors for recurrent urinary tract infections in children: exploring predictive factors and intervention measuresGuilin Wang, Jian Lin, Jiongxuan Xu, et al.
Critical Reviews in Oncology/Hematology|June 16, 2026
Challenges and Recent Advances in CAR-T Cell Therapy for Solid TumorsZhixun Guo, Dewen Zhong, Dongxue Jiao, et al.
Ecotoxicology and Environmental Safety|March 20, 2026
Mechanism of benzophenone-3 in promoting proliferation and migration of prostate cancer cells via the acyl-CoA dehydrogenase 9 axisJinhui Jian, Jiongxuan Xu, Guilin Wang, et al.
Journal of Cancer|April 30, 2019
Current Treatment for Low-Risk Prostate Cancer in China: A National Network SurveyYongbao Wei, Longfei Liu, Xin Li, et al.
Scientific Reports|August 27, 2024
Low-dose abiraterone plus Olaparib as a late-line treatment for mCRPC patients without BRCA1/2 mutations: a multicenter retrospective pilot studySijin Chen, Dewen Zhong, Chenbo Yu, et al.
Frontiers in Pharmacology|November 6, 2023
Androgen deprivation therapy plus apalutamide as neoadjuvant therapy prior radical prostatectomy for patients with unresectable prostate cancerYongbao Wei, Ruochen Zhang, Dewen Zhong, et al.
World Journal of Urology|March 27, 2024
Association between the American Heart Association's new "Life's Essential 8" metrics and kidney stoneXingmo Dong, Lihua Liao, Yani Wang, et al.
Frontiers in Pharmacology|December 19, 2025
Darolutamide-based triple therapy combined with PSMA imaging guided focal treatment in patients with prostate cancer: a multicenter retrospective studyDewen Zhong, Ruochen Zhang, Jinling Wu, et al.
Pageof 2